438 In vivo Engineered CAR-T cells for oncology using a surface-engineered lentivirus platform: nonclinical safety and biodistributionAlissa Brandes, Ryan Larson, Susana Hernández et al.|Regular and Young Investigator Award Abstracts|2023Cited by 1